For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Methenamine hippurate - Urinary Tract Infection (UTIs)
PAD Profile : Methenamine hippurate - Urinary Tract Infection (UTIs)
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed methenamine hippurate as a prophylaxis and treatment option for recurrent UTIs in men and women.
Methenamine Hippurate will be given a BLUE (under specialist recommendation) for this indication.
This is an interim position and will be reviewed when NICE guidance on UTI prophylaxis is published.
The Antimicrobial Guidelines resources can be found here Guidelines : Antimicrobial guidelines - PAD Formulary (res-systems.net)